Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

ACTA MEDICA OKAYAMA is a respected peer-reviewed journal published by Okayama University Medical School, dedicated to advancing knowledge in the fields of biochemistry, genetics, and general medicine. Established in 1972, this journal serves as a vital platform for researchers, professionals, and students to disseminate their findings and engage with ongoing scientific discussions. Based in Japan, it holds notable rankings within its categories, including Q3 in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Q4 in Medicine (miscellaneous), indicating its emerging influence in a competitive field. Although it currently does not provide open access options, the journal strives to ensure high-quality and impactful research is accessible to a wide audience, contributing to both the regional and international academic landscape. With convergence of research until the year 2024, ACTA MEDICA OKAYAMA is poised to play an increasingly significant role in the evolution of medical and biological sciences.

Khyber Medical University Journal-KMUJ, published by KHYBER MEDICAL UNIVERSITY, serves as a vital platform for the dissemination of research in the fields of Medicine, Dentistry, and Health Professions, among others. Established as an Open Access journal since 2009, KMUJ enables greater accessibility to cutting-edge research, fostering collaboration and knowledge exchange within the medical community. With its headquarters in Kohat, Khyber Pakhtunkhwa, Pakistan, the journal caters to a diverse audience by offering insights into various aspects of healthcare, emphasizing innovation and evidence-based practices. Despite its current Q4 ranking in multiple categories, KMUJ is dedicated to enhancing its impact through rigorous peer-reviewed content, aiming to elevate research standards within the region. As it converges from 2019 to 2024, KMUJ strives to contribute significantly to emerging topics in pharmacology, toxicology, and public health, making it an essential resource for researchers, professionals, and students committed to advancing medical science.

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

Gomal Journal of Medical Sciences, published by GOMAL MEDICAL COLL, serves as a vital platform for disseminating research across diverse fields within Medicine, Microbiology, and Pharmacy. As an Open Access journal since 2013, it ensures that all research findings are freely accessible to the global scientific community, promoting wider engagement and collaboration. Based in Pakistan, the journal has been indexed in Scopus and has achieved notable ranks within its categories, reflecting its commitment to quality research despite its current quartile positioning at Q4. With an objective to advance knowledge and contribute to the improvement of health sciences, the Gomal Journal of Medical Sciences encourages submissions from researchers and practitioners striving to share innovative ideas and findings. Its unique context and contribution to the regional medical field make it an indispensable resource for students, scholars, and professionals committed to advancing medical science.

YONSEI MEDICAL JOURNAL, published by the Yonsei University College of Medicine, stands as a premier open-access journal in the field of medicine since its inception. With an ISSN of 0513-5796 and an E-ISSN of 1976-2437, this esteemed journal has been diligently serving the scientific community since 1963, featuring crucial research developments that span multiple aspects of medical science. Hailing from South Korea and ranked in the Q2 category for Medicine (miscellaneous) in the 2023 Scopus rankings, it holds an impressive rank of #115 out of 636 in General Medicine, placing it in the 81st percentile. The journal is dedicated to facilitating the dissemination of knowledge through its open-access platform, which has been pivotal in enhancing visibility and accessibility for researchers, professionals, and students worldwide. As it continues to publish cutting-edge findings, YONSEI MEDICAL JOURNAL not only contributes to ongoing medical education but also fosters groundbreaking research that shapes the future of healthcare.

QJM - An International Journal of Medicine, published by Oxford University Press, stands as a cornerstone in the field of general medicine since its inception in 1907. With an impact factor that places it in the Q2 category of the 2023 Medicine (Miscellaneous) rankings, this journal ranks impressively at #57 out of 636 in its field, placing it within the top 91st percentile on Scopus. This makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest findings and developments in the medical domain. Although it does not provide open access options, QJM offers a wealth of critical insights and scholarly articles that contribute significantly to the advancement of medical knowledge and practice. Located in the United Kingdom, it continues to serve as a vital platform for disseminating innovative research and fostering academic discourse across diverse medical specialties.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.